Brand Analytics

Unleash your brand’s true potential with the
power of AI.

Create a winning commercial data and analytics strategy

In Life Sciences , a product launch can determine a company’s future—but inadequate analytics across pre-launch, launch, and post-launch phases can undermine vital commercial decisions. Drawing on our deep industry expertise and advanced technology, we help you develop a comprehensive data and analytics strategy. Unlock the insights you need to ensure a confident market entry and sustained success.

Download 5-step guide

Make proactive moves to maximize brand performance

Robust analytics are essential for driving successful product launches and measuring and optimizing brand performance in Life Sciences. Our AI/ML-driven solutions deliver timely, actionable insights—identifying empirically validated drivers of performance across the product life cycle. The result is predictive foresight that powers cohesive marketing strategies—personal, non-personal, influencer-led, and public—culminating in a top-of-mind brand fueled by hyper-personalized engagement.

Let’s talk

What do you want to
achieve?

Get comprehensive brand insights

Break down silos

Prioritize actions

Enhance decision-making

Ensure promotional mix efficacy

Develop a robust brand strategy

Brand performance

Leverage data-driven analytics across spend, campaigns, channels, territories, regions, and individual sales reps.

Let's talk

Information integration

Unlock a comprehensive view of metrics and drivers, ensuring a single version of truth.

Let's talk

Performance drivers

Use AI-powered analytics to identify and prioritize actions on performance drivers.

Let's talk

Data-driven intelligence

Enable leadership with data-driven insights and intelligence to make critical decisions.

Let's talk

Scenario planning

Compare scenarios for stronger budget planning and determine the most effective promotional mix at different stages in the life cycle.

Let's talk

Brand diagnostics evaluation framework

Get deep insights across promotion design, resourcing, allocation, institutional constraints, and macroeconomic factors.

Let's talk

Answer critical business
questions with confidence

Opportunity and threat identification

Institutional/payer constraints

HCP targeting efficiency

Promotional effectiveness

Message effectiveness

Script flow/patient pathing

Does your brand face notable threats or opportunities from imminent short-term disruptive events in your market (i.e., LOEs, new entrants, and trial results or changing behavioral patterns)?
Are the threats and opportunities concentrated among a subset of physicians and patients?
Let's talk

What percentage of physicians have restrictive levels of institutional (i.e., IDN, ACO) and/or plan constraints?
What is the mix of promotional vs. institutional payers driving choice for your brand?
Which HCPs face the most significant institutional and payer barriers?
Let's talk

Is your current HCP personal promotion targeting well-aligned with institutional and payer constraints, HCP historical responsiveness to promotion, or likely reaction to imminent market events?
What is the projected upside for your brand from modifying your targeting?
Let's talk

Is your current personal (P) and non-personal promotional (NPP) mix effective in driving choice for your brand?
Are there synergies across P/NPP and notable differences by physician and/or patient segments?
What is the projected upside for your brand from modifying your promotional emphasis and mix?
Let's talk

How effective is your current messaging strategy, and are there notable differences by physician and patient segments?
What is the potential increase in promotional effectiveness from modifying your messaging strategy overall and/or by physician segment?
Let's talk

What are the key patient journey metrics for script flow rates (rejection, abandonment), and are there differences by geography, patient types, payer/plans, etc.?
What is the potential to mitigate adverse patient-driven script outcomes (i.e., abandonment or non-compliance) through targeted programs?
Let's talk

Opportunity and threat identification

Does your brand face notable threats or opportunities from imminent short-term disruptive events in your market (i.e., LOEs, new entrants, and trial results or changing behavioral patterns)?
Are the threats and opportunities concentrated among a subset of physicians and patients?
Let's talk